» Articles » PMID: 27558816

Clearance of Dying Cells by Phagocytes: Mechanisms and Implications for Disease Pathogenesis

Overview
Date 2016 Aug 26
PMID 27558816
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

The efficient clearance of apoptotic cells is an evolutionarily conserved process crucial for homeostasis in multicellular organisms. The clearance involves a series of steps that ultimately facilitates the recognition of the apoptotic cell by the phagocytes and the subsequent uptake and processing of the corpse. These steps include the phagocyte sensing of "find-me" signals released by the apoptotic cell, recognizing "eat-me" signals displayed on the apoptotic cell surface, and then intracellular signaling within the phagocyte to mediate phagocytic cup formation around the corpse and corpse internalization, and the processing of the ingested contents. The engulfment of apoptotic cells by phagocytes not only eliminates debris from tissues but also produces an anti-inflammatory response that suppresses local tissue inflammation. Conversely, impaired corpse clearance can result in loss of immune tolerance and the development of various inflammation-associated disorders such as autoimmunity, atherosclerosis, and airway inflammation but can also affect cancer progression. Recent studies suggest that the clearance process can also influence antitumor immune responses. In this review, we will discuss how apoptotic cells interact with their engulfing phagocytes to generate important immune responses, and how modulation of such responses can influence pathology.

Citing Articles

The intricate interplay between ferroptosis and efferocytosis in cancer: unraveling novel insights and therapeutic opportunities.

Firouzjaei A, Mohammadi-Yeganeh S Front Oncol. 2024; 14:1424218.

PMID: 39544291 PMC: 11560889. DOI: 10.3389/fonc.2024.1424218.


Deciphering the multifaceted role of microRNAs in hepatocellular carcinoma: Integrating literature review and bioinformatics analysis for therapeutic insights.

Rahdan F, Saberi A, Saraygord-Afshari N, Hadizadeh M, Fayeghi T, Ghanbari E Heliyon. 2024; 10(20):e39489.

PMID: 39498055 PMC: 11532857. DOI: 10.1016/j.heliyon.2024.e39489.


Apoptotic extracellular vesicles carrying Mif regulate macrophage recruitment and compensatory proliferation in neighboring epithelial stem cells during tissue maintenance.

Essien S, Ahuja I, Eisenhoffer G PLoS Biol. 2024; 22(11):e3002194.

PMID: 39495793 PMC: 11578469. DOI: 10.1371/journal.pbio.3002194.


Clearing the Path: Exploring Apoptotic Cell Clearance in Inflammatory and Autoimmune Disorders for Therapeutic Advancements.

Ghorbanzadeh S, Khojini J, Abouali R, Alimardan S, Zahedi M, Tahershamsi Z Mol Biotechnol. 2024; .

PMID: 38935260 DOI: 10.1007/s12033-024-01222-6.


Janus kinase inhibitors modify the fatty acid profile of extracellular vesicles and modulate the immune response.

Daza Zapata A, Alvarez K, Vasquez Duque G, Palacio J, Rojas Lopez M Heliyon. 2024; 10(3):e24710.

PMID: 38314280 PMC: 10837569. DOI: 10.1016/j.heliyon.2024.e24710.


References
1.
Arur S, Uche U, Rezaul K, Fong M, Scranton V, Cowan A . Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell. 2003; 4(4):587-98. DOI: 10.1016/s1534-5807(03)00090-x. View

2.
Fond A, Lee C, Schulman I, Kiss R, Ravichandran K . Apoptotic cells trigger a membrane-initiated pathway to increase ABCA1. J Clin Invest. 2015; 125(7):2748-58. PMC: 4563683. DOI: 10.1172/JCI80300. View

3.
Prasad D, Rothlin C, Burrola P, Burstyn-Cohen T, Lu Q, Garcia de Frutos P . TAM receptor function in the retinal pigment epithelium. Mol Cell Neurosci. 2006; 33(1):96-108. DOI: 10.1016/j.mcn.2006.06.011. View

4.
Truman L, Ford C, Pasikowska M, Pound J, Wilkinson S, Dumitriu I . CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood. 2008; 112(13):5026-36. DOI: 10.1182/blood-2008-06-162404. View

5.
Miksa M, Amin D, Wu R, Ravikumar T, Wang P . Fractalkine-induced MFG-E8 leads to enhanced apoptotic cell clearance by macrophages. Mol Med. 2007; 13(11-12):553-60. PMC: 1936982. DOI: 10.2119/2007-00019.Miksa. View